Tectonic Therapeutic (TECX) Cash from Investing Activities (2017 - 2026)
Tectonic Therapeutic (TECX) posted quarterly Cash from Investing Activities of -$19000.0 for Q1 2026, up 29.63% year-over-year from -$14657.1 in Q1 2025, and up 88.55% quarter-over-quarter from -$166000.0 in Q3 2025.
Powered by 
Analysis
Tectonic Therapeutic (TECX) Cash from Investing Activities (2017 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has reported Cash from Investing Activities for 10 consecutive years, with -$19000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Investing Activities rose 29.63% year-over-year to -$19000.0; the TTM figure through Mar 2026 stood at -$130000.0 (up 27.37% YoY), while the FY2025 annual figure was -$138000.0, up 11.54% from the prior year.
- Cash from Investing Activities grew to -$19000.0 in Q1 2026 per TECX's latest filing, from -$166000.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $55000.0 in Q2 2025 and bottomed at -$214000.0 in Q2 2023.
- Historically, Cash from Investing Activities has averaged -$57266.7 across 5 years, with a median of -$27000.0 in 2025.
- Annual changes were most pronounced in 2024 — Cash from Investing Activities tumbled 2085.71% — and 2025, when it soared 1275.0%.
- Tectonic Therapeutic's Cash from Investing Activities stood at -$86000.0 in 2022, then surged by 41.86% to -$50000.0 in 2023, then soared by 94.0% to -$3000.0 in 2024, then tumbled by 5433.33% to -$166000.0 in 2025, then surged by 88.55% to -$19000.0 in 2026.
- Business Quant data shows TECX's Cash from Investing Activities at -$19000.0 in Q1 2026, -$166000.0 in Q3 2025, and $55000.0 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -45.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -92.70 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 329.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -1.66 Bn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | -49.35 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -363.46 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | -229.72 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 24.51 Mn |
| 10 | Tectonic Therapeutic | 589.02 Mn | 589.02 Mn | - | -59,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -59,000.00 |
| Mar 31, 2026 | -19,000.00 |
| Sep 30, 2025 | -166,000.00 |
| Jun 30, 2025 | 55,000.00 |
| Mar 31, 2025 | -27,000.00 |
| Dec 31, 2024 | -3,000.00 |
| Sep 30, 2024 | -153,000.00 |
| Jun 30, 2024 | 4,000.00 |
| Mar 31, 2024 | -4,000.00 |
| Dec 31, 2023 | -50,000.00 |
| Sep 30, 2023 | -7,000.00 |
| Jun 30, 2023 | -214,000.00 |
| Mar 31, 2023 | -8,000.00 |
| Sep 30, 2022 | -86,000.00 |
| Jun 30, 2022 | -149,000.00 |
| Mar 31, 2022 | -32,000.00 |
| Dec 31, 2021 | -850,000.00 |
| Sep 30, 2021 | -267,000.00 |
| Jun 30, 2021 | -1.23 Mn |
| Mar 31, 2021 | -115,000.00 |